Status:
COMPLETED
The Roles of Hilotherapy in the Management of Epistaxis and Nasal Fractures
Lead Sponsor:
Manchester University NHS Foundation Trust
Conditions:
Epistaxis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The Investigators aimed to assess primarily whether or not Hilotherapy masks are a tolerable treatment for the conservative management of epistaxis and nasal fractures.
Detailed Description
Participants who had ongoing epistaxis and met the inclusion criteria where enrolled in the pilot study . Bleeding severity was not recorded. All participants enrolled were clinically stable with acti...
Eligibility Criteria
Inclusion
- presenting to ED with epistaxis or nasal fractures ( over 18 years)
Exclusion
- laceration around site of mask, reduced GCS, concurrent head injury, systemic shock
Key Trial Info
Start Date :
May 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2019
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT04279288
Start Date
May 1 2018
End Date
August 1 2019
Last Update
February 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Manchester University Hospitals NHS Foundation Trust
Manchester, United Kingdom